Showing results (1531-1540 of 10,669) with videos related to

Sort By:
Pageof 1,067
Metabolism: Clinical and Experimental|February 1, 2025
Combined loss of glyoxalase 1 and aldehyde dehydrogenase 3a1 amplifies dicarbonyl stress, impairs proteasome activity resulting in hyperglycemia and activated retinal angiogenesisShu Li, Hao Li, Katrin Bennewitz, et al.
Metabolism: Clinical and Experimental|February 5, 2025
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapyXiaodong Wu, Yanhong Song, Zhengwei Yuan, et al.
Metabolism: Clinical and Experimental|January 29, 2025
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axisJingqiu Chen, Yilin Liao, Yue Sheng, et al.
Metabolism: Clinical and Experimental|January 1, 2025
CD36-mediated uptake of oxidized LDL induces double-negative regulatory T cell ferroptosis in metabolic dysfunction-associated steatotic liver diseaseYunxiong Wei, Yuan Jiang, Jingjing Zhu, et al.
Metabolism: Clinical and Experimental|January 1, 2025
Serum miR-365b-5p/miR-222-5p as a potential diagnostic biomarker for long-term weight loss in patients with morbid obesity after bariatric surgeryVirginia Mela, Flores Martín-Reyes, Wilfredo Oliva-Olivera, et al.
Metabolism: Clinical and Experimental|April 4, 2025
Hexosamine biosynthesis dysfunction-induced LIFR N-glycosylation deficiency exacerbates steatotic liver ischemia/reperfusion injuryRan Liu, Gengqiao Wang, Yongbing Qian, et al.
Metabolism: Clinical and Experimental|March 12, 2025
Fat absorption and metabolism after Roux-en-Y gastric bypass surgeryMorten Hindsø, Annemarie Lundsgaard, Bojan Marinkovic, et al.
Metabolism: Clinical and Experimental|December 6, 2024
Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-IXiaoqi Liu, Zixuan Zhang, Tim Aguirre, et al.
Metabolism: Clinical and Experimental|December 1, 2024
Association between the Life's essential 8 health behaviors score and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver diseaseYan Han, Jing Tang, Na Wu, et al.
Metabolism: Clinical and Experimental|November 28, 2024
Targeted metabolomics identified novel metabolites, predominantly phosphatidylcholines and docosahexaenoic acid-containing lipids, predictive of incident chronic kidney disease in middle-to-elderly-aged Chinese adultsLing Liu, Hao Cai, Handong Yang, et al.
Pageof 1,067